valcyte valganciclovir (as hydrochloride) 450 mg tablet bottle
pharmaco australia ltd - valganciclovir, quantity: 450 mg (equivalent: valganciclovir, qty 496.3 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; crospovidone; stearic acid; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400 - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prophylaxis of cmv disease in adult and paediatric solid organ transplantation (sot) patients who are at risk.
valganciclovir juno valganciclovir (as hydrochloride) 450 mg tablet bottle
juno pharmaceuticals pty ltd - valganciclovir hydrochloride -
ganciclovir gel
amici pharmaceuticals llc - ganciclovir (unii: p9g3ckz4p5) (ganciclovir - unii:p9g3ckz4p5) - ganciclovir 1.5 mg in 1 g
teva-valganciclovir tablet
teva canada limited - valganciclovir (valganciclovir hydrochloride) - tablet - 450mg - valganciclovir (valganciclovir hydrochloride) 450mg - nucleosides and nucleotides
mylan-valganciclovir tablet
mylan pharmaceuticals ulc - valganciclovir (valganciclovir hydrochloride) - tablet - 450mg - valganciclovir (valganciclovir hydrochloride) 450mg - nucleosides and nucleotides
mint-valganciclovir tablet
mint pharmaceuticals inc - valganciclovir (valganciclovir hydrochloride) - tablet - 450mg - valganciclovir (valganciclovir hydrochloride) 450mg - nucleosides and nucleotides
valganciclovir an valganciclovir (as hydrochloride) 450 mg film coated tablet bottle
juno pharmaceuticals pty ltd - valganciclovir hydrochloride -
valganciclovir 450mg tablets
teva uk ltd - valganciclovir hydrochloride - oral tablet - 450mg
valganciclovir 450mg tablets
a a h pharmaceuticals ltd - valganciclovir hydrochloride - oral tablet - 450mg
valganciclovir 450mg tablets
mawdsley-brooks & company ltd - valganciclovir hydrochloride - oral tablet - 450mg